FDA approves Abilify for treating children with autism

11/23/2009 | Bloomberg Businessweek · Disability Scoop

The FDA approved the drug Abilify for treating aggression and irritability in children ages 6 to 17 who have autism. The approval was based on two studies that showed Abilify, commonly used to treat schizophrenia, depression and bipolar disorder, improved irritability in patients given the drug compared with those given a placebo. The drug's makers said the medication should be used in combination with psychological, social and educational therapies.

View Full Article in:

Bloomberg Businessweek · Disability Scoop

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT
Sr. Product Manager - Professional Development
NWEA
Nationwide, SL_Nationwide
Sr. Product Manager - Formative Assessment Product Line
NWEA
Nationwide, SL_Nationwide
Account Executive
NWEA
Multiple Locations, SL_Multiple Locations